Table 1 Demographic and clinical characteristics of the five patients in our hospital
From: Clinical characteristics and survival outcomes of malignant struma ovarii confined to the ovary
No. | Age (y) | Dysthyroidism; Elevated CA 125 | Pathology | Surgery | Adjuvant therapy | Recurrence | Result of follow-up |
|---|---|---|---|---|---|---|---|
1 | 78 | N/N | FVPTC | Partial pancreatectomy (metastasis of clear cell carcinoma of kidney), splenectomy; USO (LSO) | N | N | NED at 40 m (Normal thyroid gland on US/WBS) |
2 | 42 | N/N | PTC | USO (LSO) | N | N | NED at 5y (Normal thyroid gland on US) |
3 | 42 | N/N | PTC | USO (LSO) | Chemotherapy (TC for 3 cycles) | N | NED at 3y (Normal thyroid gland on PET) |
4 | 56 | N/Y | PTC | USO, Debulking (TAH + RSO + omentectomy + LN) | Chemotherapy (TC for 6 cycles) | N | NED at 70 m (Normal thyroid gland on US) |
5 | 44 | N/Y | PTC | USO (LSO) | TT | N | NED at 6 m (TG undetectable); synchronous local primary PTC in neck |